NEW ZEALAND DATA SHEET - Medsafe
Version 6.0 1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME DBL™ Morphine Sulfate Injection BP 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Isotonic preparations of DBL™ Morphine Sulfate Injection BP are available in 5 …
Download NEW ZEALAND DATA SHEET - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Complete spinal block after spinal anaesthesia - …
www.frca.co.ukSign up to receive ATOTW weekly - email worldanaesthesia@mac.com COMPLETE SPINAL BLOCK FOLLOWING SPINAL ANAESTHESIA …
THORACIC PARAVERTEBRAL BLOCK: LANDMARK …
www.frca.co.ukSign up to receive ATOTW weekly - email worldanaesthesia@mac.com ATOTW 224 – Paravertebral block, Landmark Techniques 23/05/2011 Page 2 of 10
Analgesia for Labour - Anaesthesia UK
www.anaesthesiauk.comAnalgesia for Labour Labour may be the most painful experience many women ever encounter. The experience is different for each woman and the different methods chosen to relieve pain depend upon
GUIDELINE FOR ADMINISTRATION OF FENTANYL …
rcp.nshealth.caRCP PROVINCIAL GUIDELINE FOR ADMINIS TRATION OF FENTANYL1 IN LABOUR GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR INT RODUCT ION Intr avenous (IV) Fentanyl is a good option for pain management during labour and should
Oronasopharyngeal suction versus no suction in …
www.acphd.orgOronasopharyngeal suction versus no suction Australian and New Zealand Journal of Obstetrics and Gynaecology 2005; 45: 453–456 455 The maximum time to reach 86% saturation was significantly
CLINICAL AUDIT REPORT - Department of Health
www.kznhealth.gov.zaCLINICAL AUDIT REPORT LABOUR WARD LOWER UMFOLOZI DISTRICT WAR MEMORIAL HOSPITAL Dr A K M Hoque - Medical Manager Dr W Edelstein - …
120911 Nal CSL DS clean - Medsafe Home Page
www.medsafe.govt.nzNaloxone 11th Sep 2012 2 Adults For the treatment of known opioid overdose, or as an aid in the diagnosis of suspected opioid overdose. Initial dose is 0.4 – 2.0 mg intravenous
Augmentation of labour - nfog.org
www.nfog.orgAugmentation of labour Torbjørn Moe Eggebø. Stavanger University Hospital tme@sus.no Janne Rossen. Sørlandet sykehus Kristiansand. janne.Rossen@sshf.no